Skip to main content
. 2022 Sep 1;14(17):4279. doi: 10.3390/cancers14174279

Figure 2.

Figure 2

Progression-free survival and overall survival (N = 20). (A) Median PFS was 1.8 months (95% CI 1.6, 2.6), and (B) median OS was 17.2 months (95% CI 9.4, NA). Numbers above x-axis refer to number of patients.